Cell Transfection Market Expansion 2024-2033: Growth Drivers and Dynamics

The cell transfection global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Cell Transfection Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The cell transfection market size has grown strongly in recent years. It will grow from $1.19 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to surge in CRISPR and gene editing studies, rising funding from governments and non-governmental organizations, increasing clinical trials involving transfected cells, expansion of academic research in molecular biology, growing popularity of high-throughput screening methods.

The cell transfection market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising demand for gene therapy, rising prevalence of chronic diseases, expansion of biopharmaceutical manufacturing, growth in proteomics and genomics research, growing applications of RNA-based therapeutics. Major trends in the forecast period include increasing investment in biotech and pharmaceutical research and development, advancements in transfection technologies, adoption of personalized medicine, use of transfection in cancer research, development of novel transfection reagents and kits.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Scope Of Cell Transfection Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Cell Transfection Market Overview

Market Drivers –
The increase in the number of cases of infectious disease is expected to propel the growth of the cell transfection market going forward. Infectious diseases are illnesses caused by germs that spread from one person to another or through contaminated sources. Inadequate public health infrastructure, coupled with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection is a powerful tool for infectious diseases because it allows scientists to insert genes into cells to study how infections affect them and to test new treatments. For instance, in September 2023, according to a report published by the Australian Bureau of Statistics, an Australia-based government agency, in 2021, influenza and pneumonia-associated death rate was 31.5 per 100,000, which reached 42.6 per 100,000 in 2022. Therefore, the increase in the number of cases of infectious diseases drives the cell transfection market.

Market Trends –
Major companies operating in the cell transfection market are integrating innovations into transfection systems to enable precise control over gene expression. A transfection system is a technique or technology designed to introduce foreign nucleic acids into cells to study gene function, produce proteins, or alter gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system. It is a novel tool designed to enhance cell engineering research. This system employs advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, addressing limitations associated with traditional transfection methods. It can transfect up to 10 million cells per second, making it suitable for large-scale applications. The system is compatible with various cell types, including T cells and hematopoietic stem cells. It can deliver diverse cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods
2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Get an inside scoop of the cell transfection market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Regional Insights –
North America was the largest region in the cell transfection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Table of Contents

1. Executive Summary
2. Cell Transfection Market Report Structure
3. Cell Transfection Market Trends And Strategies
4. Cell Transfection Market – Macro Economic Scenario
5. Global Cell Transfection Market Size and Growth
.
.
.
32. Global Cell Transfection Market Competitive Benchmarking
33. Global Cell Transfection Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Transfection Market
35. Cell Transfection Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model